Vineet Jindal | IR |
Warren Huff | Chairman, CEO & President |
Jason Wilson | CFO & VP of Strategy |
Colin Meyer | Chief Medical Officer & VP of Product Development |
Maurice Raycroft | Jefferies |
Yigal Nochomovitz | Citigroup |
Adam Walsh | Stifel, Nicolaus & Company |
Joseph Schwartz | Leerink Partners |
Brian Skorney | Robert W. Baird & Co. |
Good day, ladies and gentlemen, and welcome to Reata Pharmaceuticals' Update on Development Programs Conference Call. [Operator Instructions]. An audio recording of today's webcast will be available shortly after the call today on Reata's website at reatapharma.com in the Investors & News section.
Before the company proceeds with its remarks, please note the forward-looking statements disclosure in the company's press release. The company will be making forward-looking statements on today's call.